Logo image of KIN

Kindred Biosciences (KIN) Stock Analyst Earnings Estimates

NASDAQ:KIN - Nasdaq -

9.25  +0.01 (+0.11%)

After market: 9.26 +0.01 (+0.11%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
KIN revenue by date.KIN revenue by date.
N/AN/AN/AN/AN/AN/A
117.91%
N/A
917.89%
N/A
-49.68%
N/A
92.48%
N/A
13.54%
N/A
50.75%
N/A
53.01%
EBITDA
YoY % growth
KIN ebitda by date.KIN ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
KIN ebit by date.KIN ebit by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Margin
KIN operating margin by date.KIN operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
KIN eps by date.KIN eps by date.
-1.45-1.37
5.52%
-1.10
19.71%
-1.23
-11.82%
-1.60
-30.08%
-1.58
1.25%
-0.47
70.25%
N/A
-51.22%
N/A
90.05%
N/A
-197.14%
N/A
54.01%
N/A

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 21 Q4 / 21 Q1 / 22 Q2 / 22 Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth
-0.19
37.28%
-0.13
54.01%
-0.16
34.77%
-0.15
25.92%
0.23
216.00%
-0.13
-4.55%
-0.11
29.03%
-0.09
38.65%
-0.07
-131.35%
-0.05
62.49%
Revenue
Q2Q % growth
4.738M7.59M5.763M
64.36%
6.443M
17.55%
30.33M
540.15%
7.39M
-2.64%
11.368M
97.25%
12.789M
98.48%
14.21M
-53.15%
15.631M
111.52%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

Recent Earnings VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
Q2 2021
Q2Q % growth
-0.20
-130.77%
-0.17-0.03-20.89%
Q1 2021
Q2Q % growth
-0.24
54.72%
-0.240.001.69%
Q4 2020
Q2Q % growth
-0.28
30.00%
%
Q3 2020
Q2Q % growth
-0.31
20.51%
%
Q2 2020
Q2Q % growth
0.65
275.68%
%
Q1 2020
Q2Q % growth
-0.53
-26.19%
%
KIN Yearly EPS VS EstimatesKIN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -0.5 -1 -1.5
Recent Revenue VS Estimates Surprises

Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .

PeriodReportedEstimateDifferenceSurprise
KIN Yearly Revenue VS EstimatesKIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A